AEF0217 is a first-in-class Signalling Specific inhibitor of the CB1 receptor (CB1-SSi) developed as a treatment for impairments in adaptive behaviours and cognition in neurodevelopmental disorders ...
BY KARISSA MILLER Union Grove Elementary School has taken a major step toward creating a more inclusive environment for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results